Primary objective of the study is the assessment of the patients' discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.
Participants will be recruited from the Cataract Service of the University Hospital of Alexandroupolis (UHA), the Naval Hospital in Athens, the Papanikolaou General Hospital in Thessaloniki, and Athinaiki General Clinic in Athens in a consecutive-if-eligible basis. By means of a custom computer randomization program all participants will randomly populate either study group \[who will receive fixed combination of tobramycin and dexamethasone (FCTD), (Tobradex, Alcon, Greece) quid for 3 weeks and 0.2 % sodium hyaluronate (Hylogel, Pharmex, Greece) quid for 6 weeks\], and control group \[who will receive Tobradex quid for 3 weeks and 0.1 % sodium hyaluronate (Hylocomod) quid for 6 weeks\].
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
180
Patients will be administered Drops of Sodium Hyaluronate 0.1% quid
Patients will be administered Drops of Sodium Hyaluronate 0.2% quid
University Hospital of Alexandroupolis
Alexandroupoli, Evros, Greece
Surface Discomfort Index
A subjective parameter that quantifies corneal discomfort
Time frame: 6 weeks
Break up time
An objective parameter that quantifies stability of tear film
Time frame: 6 weeks
Central Corneal Sensitivity
An objective parameter that quantifies corneal sensitivity
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.